Nicolas Bery researcher ORCID ID = 0000-0002-2643-3897
Bery, Nicolas, 1986-....
VIAF ID: 167145003317461301464 (Personal)
Permalink: http://viaf.org/viaf/167145003317461301464
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Bioluminescence Resonance Energy Transfer 2 (BRET2)-Based RAS Biosensors to Characterize RAS Inhibitors | |
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. | |
Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cells | |
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe | |
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies. | |
A new way to target RhoB GTPase : set up of selective conformational intrabodies and their functionalization to promote inhibition of small GTPase RhoB cellular activity. | |
Nouvelle stratégie de ciblage de la GTPase RhoB : développement d'intracorps conformationnels sélectifs et leur fonctionnalisation en tant qu'inhibiteurs intracellulaires de l'activité de RhoB | |
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS | |
Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities | |
Single domain antibodies with VH hallmarks are positively selected during panning of llama (Lama glama) naïve libraries. | |
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange. | |
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds | |
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model | |
A Targeted Protein Degradation Cell-Based Screening for Nanobodies Selective toward the Cellular RHOB GTP-Bound Conformation |